IL35 Receptor (SJ-08-0039)

Technology Name
(St. Jude Reference #)
IL35 Receptor (SJ-08-0039)
Description The receptor for the IL-35 cytokine closely associated with Tregs can be used to develop methods to block or augment IL35R signaling to block or boost, respectively, IL-35 activity. This could be used to treat autoimmune and inflammatory diseases. Methods that block/inhibit IL35R signaling could be used to treat any condition in which the IL-35-mediated activity of Tregs is shown to blocking/limiting disease resolution such as cancer and chronic inflammatory disease.
Keywords Receptor,IL-35 cytokine ,Tregs, autoimmune and inflammatory disease, cancer
Granted Patents or Published Applications UD application published as US 13/509,072
Related Scientific References  
Licensing Opportunities We are currently seeking nonexclusive licensing opportunities in all fields for the development of this technology.


Contact the Office of Technology Licensing (Phone: 901-595-2342, Fax: 901-595-3148) for more information.


Last update: August 2013

Sign up for licensing bulletins

or browse our technology